Whole-Mount Immunostaining and Automatic Counting of Mouse Retinal Ganglion Cells(전체 마운트 면역염색 및 마우스 망막 신경절 세포의 자동 계수)

Overview

This study outlines a protocol for isolating the whole-mount mouse retina and conducting immunostaining to label retinal ganglion cells (RGCs). Utilizing an AI-based software for automated counting allows for a rapid and accurate quantification of RGCs, facilitating the study of conditions like glaucoma.

Key Study Components

Area of Science

• Neuroscience
• Retinal anatomy
• Glaucoma research

Background

• Retinal ganglion cells are crucial for visual processing.
• Manual counts of RGCs can be time-consuming and labor-intensive.
• Automation in counting using AI is a promising alternative.
• Understanding RGC loss is vital for studying glaucoma.

Purpose of Study

• To develop a method for rapid quantification of retinal ganglion cells.
• To facilitate glaucoma research by efficiently assessing RGC loss.
• To utilize automated tools to improve accuracy in cell counting.

Methods Used

• The main platform involves whole-mount retina isolation and immunostaining.
• The biological model employed is the mouse retina, particularly in the context of glaucoma.
• Key steps include fixation, antibody incubation, and image processing using AI software.
• The protocol emphasizes careful dissection and handling of the retina to maintain tissue integrity.

Main Results

• Automated counting accurately identified over 15,000 RGCs in a glaucoma mouse model.
• Significant cell loss was observed compared to healthy retinas, which contain approximately 50,000 RGCs.
• This method enhances efficiency and reduces manual errors in cell counting.

Conclusions

• The study demonstrates a streamlined approach to RGC quantification using AI.
• This method holds promise for advancing research in glaucoma treatment and retinal health.
• Implications extend to understanding RGC loss and potential therapies for retinal diseases.

Frequently Asked Questions